Correlation between diabetic nephropathy and diabetic retinopathy as a long term complications of diabetes mellitus
References
- Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. New York (USA): McGraw Hill Education; 2018. Harrison’s Principles of Internal Medicine 20th ed. Alvin CP, Kevin DN, Carmella EM. Chapter No. 396 Diabetes Mellitus: Diagnosis, Classification, and Pathophysiology; 2850.
- Saini DC, Kochar A, Poonia R. Clinical correlation of diabetic retinopathy with nephropathy and neuropathy. Indian J Ophthalmol. 2021;69(11):3364-3368.
- Yang Z, Tan TE, Shao Y, Wong TY, Li X. Classification of diabetic retinopathy: Past, present and future. Front Endocrinol (Lausanne). 2022;13:1079217.
- Gregory GA, Robinson TIG, Linklater SE, Wang F, Colagiuri S. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol. 2022;10(10):741-760.
- Liu X, Zhou X, Song W, Zeng J, Niu X. The Diagnostic Value of Circulating VEGF in Diabetic Retinopathy in Asia: A Systematic Review and Meta-analysis. Ophthalmic Epidemiol. 2022:1-9.
- Raman R, Rani PK, Rachepalle SR, Gnaanamurthy P, Uthra S. Prevalence of diabetic retinopathy in India: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetics study report 2. Ophthalmology. 2009;116:311–8.
- Li L, Yang K, Li C, Zhang H, Yu H, Chen K, et al. Metagenomic shotgun sequencing and metabolomic profiling identify specific human gut microbiota associated with diabetic retinopathy in patients with type 2 diabetes. Front Immunol. 2022;13:943325.
- Sun XJ, Zhang GH, Guo CM, Zhou ZY, Niu YL, Wang L, et al. Associations between psycho-behavioral risk factors and diabetic retinopathy: NHANES (2005-2018). Front Public Health. 2022;10:966714.
- Jawa A, Kcomt J, Fonseca VA. Diabetic nephropathy and retinopathy. Med Clin N Am. 2004;88:1001–36.
- Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, Uribarri J. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102(2):248-260.
- Pastor-Fajardo MT, Fajardo-Giménez MT, Bosch-Giménez VM, Pastor-Rosado J. Changes from 1986 to 2018 in the prevalence of obesity and overweight, metabolic control and treatment in children with type 1 diabetes mellitus in a Mediterranean area of Southeast Spain. BMC Pediatr. 2022;22(1):274.
- UK Prospective Diabetes Study Group. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. Br Med J.1998;317:720–726.
- Yang J, Liu Z. Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy. Front Endocrinol (Lausanne). 2022;13:816400.
- Rando MM, Guthoff M, Tiwari V, Biscetti F. Editorial: Diagnosis, prevention and treatment in diabetic nephropathy. Front Endocrinol (Lausanne). 2022;13:1011665.
- Navarro J, Sanchez A, Ba Aqeel SH, Ye M, Rehman MZ, Wysocki J, Rademaker A, Molitch ME, Batlle D. Urinary Angiotensinogen in Patients With Type 1 Diabetes With Microalbuminuria: Gender Differences and Effect of Intensive Insulin Therapy. Kidney Int Rep. 2022;7(12):2657-2667.
- Nuffield Department of Population Health Renal Studies Group; SGLT2 inhibitor meta-analysis Cardio-Renal Trialists’ Consortium. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: Collaborative meta-analysis of large placebo-controlled trials. Lancet. 2022;400(10365):1788-1801.
- Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021;12(8):1322-1325.
- Klein R, Klein BEK, Moss SE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XIV. Ten year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994;112:1217-28.
- Klein R, Klein BEK,Moss SE, et all.Retinopathy in young onset diabetic patients.Diabetes Care 1995;8:311-5.
- Samsu N. Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. Biomed Res Int. 2021;2021:1497449.
- Ehtewish H, Arredouani A, El-Agnaf O. Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline. Int J Mol Sci. 2022; 23(11):6144.
- Vilsbøll T, Bain SC, Leiter LA, Lingvay I, Matthews D, Simó R, et al. Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy. Diabetes Obes Metab. 2018;20(4):889-897.
- Tan TE, Wong TY. Diabetic retinopathy: Looking forward to 2030. Front Endocrinol (Lausanne). 2023;13:1077669.
- Wang N, Wei L, Liu D, Zhang Q, Xia X, Ding L, et al. Identification and Validation of Autophagy-Related Genes in Diabetic Retinopathy. Front Endocrinol (Lausanne). 2022;13:867600.
- Dinesen S, Stokholm L, Subhi Y, Peto T, Savarimuthu TR, Andersen N, et al. Five-Year Incidence of Proliferative Diabetic Retinopathy and Associated Risk Factors in a Nationwide Cohort of 201 945 Danish Patients with Diabetes. Ophthalmol Sci. 2023;3(3):100291.
Language: English
Page range: 176 - 181
Submitted on: Mar 6, 2023
Accepted on: May 21, 2023
Published on: Sep 28, 2023
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2023 Muamer Dervišević, Damir Rebić, Emina Dervišević, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.